Roferon-A



Indications and Reactions:

Role Indications Reactions
Primary
Malignant Melanoma 16.2%
Renal Cell Carcinoma 14.0%
Hepatitis C 11.8%
Drug Use For Unknown Indication 8.5%
Metastatic Renal Cell Carcinoma 7.4%
Product Used For Unknown Indication 6.6%
Pain 4.8%
Hypertension 4.4%
Renal Cell Carcinoma Stage Unspecified 3.3%
Chronic Myeloid Leukaemia 3.0%
Renal Cancer 3.0%
Antiviral Treatment 2.6%
Prophylaxis Against Transplant Rejection 2.6%
Essential Thrombocythaemia 2.2%
Glaucoma 2.2%
Analgesic Therapy 1.5%
Contraception 1.5%
Hepatitis 1.5%
Plasmacytoma 1.5%
Sedation 1.5%
Tinnitus 7.8%
Weight Decreased 7.8%
Pulmonary Fibrosis 6.3%
Pyrexia 6.3%
Thrombocytopenia 6.3%
Thrombotic Microangiopathy 6.3%
Blister 4.7%
Breast Cancer 4.7%
Circulatory Collapse 4.7%
Diarrhoea 4.7%
Guillain-barre Syndrome 4.7%
Hip Surgery 4.7%
Liver Function Test Abnormal 4.7%
Retinal Haemorrhage 4.7%
Skin Infection 4.7%
Suicidal Ideation 4.7%
Asthenia 3.1%
Atrial Fibrillation 3.1%
Atrioventricular Block 3.1%
Basedow's Disease 3.1%
Secondary
Prophylaxis 24.4%
Renal Cell Carcinoma 16.8%
Metastatic Renal Cell Carcinoma 11.6%
Hypertension 5.0%
Hepatitis C 4.4%
Renal Cancer 4.0%
Prophylaxis Of Nausea And Vomiting 3.9%
Product Used For Unknown Indication 3.6%
Renal Cancer Metastatic 3.6%
Pain Prophylaxis 2.6%
Metastatic Malignant Melanoma 2.5%
Chronic Myeloid Leukaemia 2.3%
Polycythaemia Vera 2.3%
Hypothyroidism 2.2%
Hepatitis B 1.9%
Malignant Melanoma 1.9%
Diabetes Mellitus 1.8%
Drug Use For Unknown Indication 1.8%
Depression 1.7%
Essential Thrombocythaemia 1.6%
Anaemia 11.1%
Hypertension 7.8%
Pyrexia 7.8%
Renal Failure 6.7%
Thrombocytopenia 6.7%
Decreased Appetite 5.6%
Cerebral Infarction 4.4%
Completed Suicide 4.4%
Diarrhoea 4.4%
Gastrointestinal Perforation 4.4%
Hip Fracture 4.4%
Nausea 4.4%
Type 1 Diabetes Mellitus 4.4%
Bronchitis 3.3%
Dehydration 3.3%
Diabetic Neuropathy 3.3%
Drug Intolerance 3.3%
Haemoptysis 3.3%
Hemiparesis 3.3%
Intestinal Obstruction 3.3%
Concomitant
Renal Cell Carcinoma 14.0%
Renal Cancer 12.8%
Drug Use For Unknown Indication 11.6%
Metastatic Renal Cell Carcinoma 9.3%
Tuberculosis 9.3%
Lymphoma 7.0%
Hypertension 4.7%
Multiple Myeloma 4.7%
Non-hodgkin's Lymphoma 4.7%
Bone Disorder 3.5%
Chronic Myeloid Leukaemia 3.5%
Pain 2.3%
Pulmonary Hypertension 2.3%
Renal Cell Carcinoma Stage Unspecified 2.3%
Transplant 2.3%
Coronary Artery Disease 1.2%
Deep Vein Thrombosis 1.2%
Diabetes Mellitus 1.2%
Hyperuricaemia 1.2%
Osteoporosis Postmenopausal 1.2%
Hemiparesis 13.2%
Skin Necrosis 13.2%
Osteonecrosis 7.9%
Pyrexia 7.9%
Bone Fistula 5.3%
Cerebrovascular Accident 5.3%
Drug Exposure During Pregnancy 5.3%
Gastric Ulcer Haemorrhage 5.3%
Spinal Osteoarthritis 5.3%
Vomiting 5.3%
Chest Discomfort 2.6%
Gastrointestinal Haemorrhage 2.6%
Haemorrhagic Anaemia 2.6%
Hypertension 2.6%
Mucosal Inflammation 2.6%
Oxygen Saturation Decreased 2.6%
Pregnancy 2.6%
Proteinuria 2.6%
Pulmonary Hypertension 2.6%
Renal Cell Carcinoma 2.6%